{"id":47491,"date":"2021-10-27T08:00:00","date_gmt":"2021-10-27T06:00:00","guid":{"rendered":"https:\/\/www.stille.se\/se\/mfn_news\/stille-ab-kvartalsrapport-q3-2021\/"},"modified":"2024-04-14T16:45:56","modified_gmt":"2024-04-14T14:45:56","slug":"stille-ab-kvartalsrapport-q3-2021","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/se\/nyheter\/stille-ab-kvartalsrapport-q3-2021\/","title":{"rendered":"Stille AB: Kvartalsrapport Q3 2021"},"content":{"rendered":"
Stille AB (publ) redovisar idag rapporten f\u00f6r det tredje kvartalet 2021. \u201dEtt kvartal med stark tillv\u00e4xt\u201d, summerar Stilles VD Hanna Ernestam Wilkman.<\/strong><\/div>\n

Stille har under det tredje kvartalet levererat tillv\u00e4xt b\u00e5de organiskt och genom f\u00f6rv\u00e4rvet av det schweiziska bolaget S&T AG. Den organiska oms\u00e4ttningen \u00f6kade med 12 procent j\u00e4mf\u00f6rt med samma kvartal f\u00f6reg\u00e5ende \u00e5r.\u00a0<\/span><\/span><\/p>\n

\u201dF\u00f6rv\u00e4rvet av S&T inneb\u00e4r att storleken p\u00e5 aff\u00e4rsomr\u00e5de Kirurgiska instrument f\u00f6rdubblats. Integrationen av bolaget fortskrider enligt plan och utg\u00f6r en viktig del av v\u00e5r tillv\u00e4xtstrategi. Huvudfokus \u00e4r att realisera identifierade cross-selling synergier inom s\u00e5v\u00e4l produkt som f\u00f6rs\u00e4ljningskanal med syfte att \u00f6ka tillv\u00e4xten\u201d<\/em>, s\u00e4ger Hanna Ernestam Wilkman.<\/span><\/span><\/p>\n

Totalt \u00f6kade oms\u00e4ttningen f\u00f6r b\u00e5de aff\u00e4rsomr\u00e5de Kirurgiska instrument (44%) och Operationsbord (14%).<\/span><\/span><\/p>\n

\u201dDet \u00e4r framf\u00f6r allt gl\u00e4djande att expansionen i USA forts\u00e4tter med en tillv\u00e4xt om hela 34%. Detta trots st\u00f6rningar i f\u00f6rs\u00f6rjningskedjan som \u00e4ven forts\u00e4ttningsvis kan komma att p\u00e5verka verksamheten. N\u00e4r vi nu kliver in i det fj\u00e4rde kvartalet, g\u00f6r vi det med en stark optimism g\u00e4llande bolagets fortsatta utveckling\u201d<\/em>, avslutar Stilles VD.<\/span><\/span><\/p>\n

Fortsatt stark tillv\u00e4xt under tredje kvartalet<\/span><\/h3>\n
    \n
  • Nettooms\u00e4ttningen uppgick till 51,1 MSEK (31,5).<\/span><\/li>\n
  • Bruttomarginalen uppgick till 45,0 procent (43,7).<\/span><\/li>\n
  • R\u00f6relseresultatet uppgick till 5,5 MSEK (2,6), vilket motsvarar en r\u00f6relsemarginal p\u00e5 10,7 procent\u00a0(8,3). R\u00f6relseresultatet \u00e4r belastat med -1,5 MSEK (0,0) i transaktionskostnader.<\/span><\/li>\n
  • Resultatet efter skatt uppgick till 3,4 MSEK (1,5), vilket motsvarar 6,7 procent (4,8) av nettooms\u00e4ttningen.<\/span><\/li>\n
  • Kassafl\u00f6de fr\u00e5n den l\u00f6pande verksamheten uppgick till 6,9 MSEK (-0,8).<\/span><\/li>\n
  • Den 8 juli 2021 f\u00f6rv\u00e4rvade Stille 100% av aktierna i det schweiziska bolaget S&T AG.<\/span><\/li>\n
  • F\u00f6rvaltningsr\u00e4tten har beslutat att upph\u00e4va Tillv\u00e4xtverkets beslut att avsl\u00e5 bolagets ans\u00f6kan om st\u00f6d vid korttidsarbete.<\/span><\/li>\n<\/ul>\n\n\n\n\n\n\n\n\n\n
    MSEK<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\njul-sept
    \n\t\t\t2021<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n    		jul-sept
    \n\t\t\t2020<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n    		jan-sept
    \n\t\t\t2021<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n    		jan-sept<\/span><\/span><\/strong>
    \n\t\t\t2020<\/span><\/span><\/strong><\/span><\/span><\/span><\/span><\/span><\/td>\n    		okt\/sept 20\/21<\/span><\/span><\/strong><\/span><\/span><\/span><\/td>\njan-dec
    \n\t\t\t2020<\/span><\/span><\/strong><\/span><\/span><\/span><\/td>\n<\/tr>\n
    Nettooms\u00e4ttning,<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n51,1<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n31,5<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n127,5<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n97,6<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n172,5<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n142,6<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n
    R\u00f6relseresultat inkl. transaktionskostnader<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n5,5<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n2,6<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n14,6<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n5,9<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n23,3<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n14,5<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n
    R\u00f6relsemarginal inkl. transaktionskostnader, %<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n10,7<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n8,3<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n11,4<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n6,0<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n13,5<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n10,2<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n
    Resultat f\u00f6re skatt<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n6,0<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n2,0<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n15,8<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n5,1<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n21,5<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n10,8<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n
    Periodens resultat<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n3,4<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n1,5<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n10,2<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n3,9<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n14,6<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n8,3<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n
    Resultat efter skatt per aktie, SEK<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n0,68<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n0,32<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n2,03<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n0,80<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n2,91<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n1,71<\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Torsh\u00e4lla den 27 oktober 2021.<\/span><\/p>\n<\/p>\n

    \n

    F\u00f6r ytterligare information, v\u00e4nligen kontakta:\u00a0<\/span><\/span><\/p>\n

    Hanna Ernestam Wilkman<\/strong>
    \nVD och koncernchef
    \n+46 (0)72 402 10 88 | hanna.e.wilkman@stille.se<\/span><\/span><\/p>\n<\/div>\n

    \n

    STILLE AB (publ) utvecklar, tillverkar och marknadsf\u00f6r medicintekniska produkter f\u00f6r specialistkirurger v\u00e4rlden \u00f6ver. Stille grundades 1841 och \u00e4r ett av v\u00e4rldens \u00e4ldsta f\u00f6retag inom medicinteknik. Stilles prioriterade aff\u00e4rsomr\u00e5den \u00e4r kirurgiska instrument och operationsbord. Stilles kirurgiska instrument anv\u00e4nds framf\u00f6rallt vid olika typer av \u00f6ppen kirurgi. N\u00e4r det g\u00e4ller minimalinvasiva ingrepp \u00e4r operationsborden imagiQ2 och Medstone nyckelprodukter. Bolaget har en stabil bas med ett starkt varum\u00e4rke och v\u00e4lk\u00e4nda produkter av erk\u00e4nt h\u00f6g kvalitet.\u00a0<\/span><\/span><\/p>\n

    Aktien \u00e4r noterad p\u00e5 marknadsplatsen First North Growth Market under kortnamnet \u201dSTIL\u201d med Eminova AB som Certified Adviser. Eminova Fondkommission AB + 46 8 684 211 10, adviser@eminova.se. Denna information \u00e4r s\u00e5dan information som Stille AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 27 oktober\u00a02021 kl. 08.00.\u00a0<\/span><\/span>F\u00f6r mer information om Stille bes\u00f6k www.stille.se.<\/span><\/span><\/p>\n<\/div>\n